PMA device
LVIS and LVIS Jr.
MicroVention, Inc. · Intracranial Coil-Assist Stent (QCA, Class III) · First FDA decision Nov 17, 2020, newest Nov 17, 2020Brain aneurysm
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
15
Naming "LVIS"
MAUDE reports
440
Brand "LVIS", since 2015
PubMed studies
306
Mentioning "LVIS"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing LVIS and LVIS Jr.
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- LVIS and LVIS Jr.PMA supplement
P170013-S001 · Decided Nov 17, 2020 · 845 days after receipt · Normal 180 Day Track No User Fee
Device type: Intracranial coil-assist stent (QCA) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Magnetic Resonance Angiography of the Abdomen and PelvisNational analysisReview closedCAG-00142NUpdated Sep 15, 2026
- CT of the Abdomen and PelvisLocal determinationIn effectL34415Palmetto GBAUpdated Jul 7, 2022
- Intracranial Stenting and AngioplastyNational analysisReview closedCAG-00085R5Updated Sep 18, 2026
- Intracranial Stenting and AngioplastyNational analysisReview closedCAG-00085R2Updated Sep 18, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "LVIS", any status and sponsor, newest update first.
Microvention-Terumo, Inc.Public (4543.T)
NCT06494436 · 1,000 participants (planned) · Start Dec 30, 2024 · Primary completion Dec 30, 2029
Device: All Microvention Class III implantable device CE marked; All Microvention Mechanical Thrombectomy Class III device CE marked · For: Intracranial Aneurysm; Intracranial Aneurysm, Wide Neck Aneurysm, Large Neck Aneurysm Lesion; Aneurysmal Subarachnoid Hemorrhage and 2 more
Sites: Vigo, Spain
- Efficacy and Safety of the Self-expanding Intracranial Stent (Tonbridge) for Endovascular Treatment of Intracranial AneurysmsPivotal-lookingCompleted
Ton-Bridge Medical Tech. Co., LtdNot on our public-company list
NCT05755516 · 204 participants · Start Feb 14, 2023 · Primary completion Mar 10, 2024
Device: Self-expanding Intracranial Stent (Tonbridge); LVIS and LVIS Jr. (MicroVention) · For: Intracranial Aneurysm
Sites: Wuhu, China; Guangzhou, China; Zhuhai, China · 14 sites in all
Microvention-Terumo, Inc.Public (4543.T)
NCT01541254 · 30 participants · Start Mar 2012 · Primary completion Jun 2013
Device: Low profile Visualized Intraluminal Device (LVIS and LVIS Jr.) · For: Intracranial Aneurysms
Sites: Albany, New York; Stony Brook, New York; Philadelphia, Pennsylvania · 6 sites in all
12 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "LVIS", and for the whole product code for context.
This brand
440 reports: 123 malfunction, 286 injury, 30 death
Whole product code QCA
880 reports: 599 malfunction, 270 injury, 11 death
Newest reports for this brand
- LVIS EVOMalfunction
2032493-2026-08319 · Received Oct 22, 2026 · Event dated Sep 25, 2026
Device type: Intracranial Coil-Assist Stent (QCA)
Device problem as coded: Retraction Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- LVIS EVOInjury
2032493-2026-08308 · Received Oct 16, 2026 · Event dated Sep 16, 2026
Device type: Intracranial Coil-Assist Stent (QCA)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Ischemia Stroke; Thrombosis/Thrombus
- LVIS DMalfunction
2032493-2026-08298 · Received Oct 14, 2026 · Event dated Sep 15, 2026
Device type: Intracranial Coil-Assist Stent (QCA)
Device problem as coded: Retraction Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2200-2026 · Started Apr 6, 2026 · Posted by FDA May 14, 2026
Reason given: Stent-assisted coiling device may due to commingling during manufacturing have dimensional nonconformance and/or incorrect device configuration. If device is oversized may lead to increased vessel wall stress, neointimal hyperplasia, vessel injury/rupture; if undersized may lead to incomplete expansion/malposition,...
Cause as FDA categorized it: Mixed-up of materials/components · Device type: Intracranial Coil-Assist Stent (QCA)
Z-1121-2025 · Started Dec 11, 2024 · Posted by FDA Feb 7, 2025
Reason given: Potential for Polytetrafluoethylene (PTFE) material encasing the stent loop may prevent the stent from being pushed out of the introducer.
Cause as FDA categorized it: Nonconforming Material/Component · Device type: Intracranial Coil-Assist Stent (QCA)
Published research
The most relevant PubMed records for "LVIS"[tiab]. The summary above synthesizes these.
- LVIs and certification.
Vet Rec · 1995Editorial
- LVIS EVO stent-assisted coiling for intracranial aneurysms: results of long-term follow-up.
Wei F, Geismar M, Kalsoum E, et al. · Neuroradiology · 2025
- LVIS versus enterprise stents for stent-assisted coiling of intracranial aneurysms: a systematic review and meta-analysis.
Tamara Alves Carretta L, Ribeiro Gonçalves O, Lee Han M, et al. · Neuroradiology · 2025Systematic Review, Meta-Analysis
- LVIS-within-enterprise double-stent procedure without coiling beneficial as treatment of unruptured vertebral artery dissecting aneurysms.
Choi HH, Cho YD, Yoo DH, et al. · Interv Neuroradiol · 2022
- [Neck Bridge Stent].
Arimura K · No Shinkei Geka · 2026Review, English Abstract
- LVIS EVO stent-through-balloon after hydrocoil embolization of intracranial aneurysms: One-year results.
Mosimann PJ, Yamac E, Wallocha M, et al. · Interv Neuroradiol · 2024Observational Study
- Comparison of LVIS and Enterprise stent-assisted coiling embolization for ruptured intracranial aneurysms: a propensity score-matched cohort study.
Shu L, Xiao B, Jiang Y, et al. · Neurosurg Rev · 2024Clinical Trial, Comparative Study
- LVIS-within-enterprise double-stent technique with coil embolization in the treatment of patients with acutely ruptured intracranial vertebrobasilar artery-dissecting aneurysms.
Wu Q, Meng Y, Chen A, et al. · Front Neurol · 2023
- LVIS Stent Versus Enterprise Stent for the Treatment of Unruptured Intracranial Aneurysms.
Ge H, Lv X, Yang X, et al. · World Neurosurg · 2016Comparative Study
- Safety and Efficacy of LVIS Jr Stent-assisted Coiling of Intracranial Aneurysms in Small-diameter Parent Arteries : A Single-center Experience.
Shi S, Long S, Hui F, et al. · Clin Neuroradiol · 2024
- Canadian Registry of LVIS Jr for Treatment of Intracranial Aneurysms (CaRLA).
Shankar JJS, Quateen A, Weill A, et al. · J Neurointerv Surg · 2017Multicenter Study
- Initial Experience with LVIS EVO Stents for the Treatment of Intracranial Aneurysms.
Poncyljusz W, Kubiak K · J Clin Med · 2020
Other devices of this type
Also filed under product code QCA.
- Low-Profile Visualized Intraluminal Support (LVIS), LVIS JrMicroVention, Inc. · PMA 2024
- Neuroform Atlas® Stent SystemStryker Neurovascular · PMA 2026
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.